DE60235900D1 - osuppressivum - Google Patents

osuppressivum

Info

Publication number
DE60235900D1
DE60235900D1 DE2002635900 DE60235900A DE60235900D1 DE 60235900 D1 DE60235900 D1 DE 60235900D1 DE 2002635900 DE2002635900 DE 2002635900 DE 60235900 A DE60235900 A DE 60235900A DE 60235900 D1 DE60235900 D1 DE 60235900D1
Authority
DE
Germany
Prior art keywords
osuppressivum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE2002635900
Other languages
German (de)
Inventor
Yasushi Kohno
Naoki Ando
Takahiro Tanase
Kazuhiko Kuriyama
Satoru Iwanami
Shinji Kudou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2001297400 priority Critical
Priority to JP2002216191 priority
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Priority to PCT/JP2002/009864 priority patent/WO2003029184A1/en
Application granted granted Critical
Publication of DE60235900D1 publication Critical patent/DE60235900D1/en
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/64Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
DE2002635900 2001-09-27 2002-09-25 osuppressivum Active DE60235900D1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2001297400 2001-09-27
JP2002216191 2002-07-25
PCT/JP2002/009864 WO2003029184A1 (en) 2001-09-27 2002-09-25 Diaryl ether derivative, addition salt thereof, and immunosuppressant

Publications (1)

Publication Number Publication Date
DE60235900D1 true DE60235900D1 (en) 2010-05-20

Family

ID=26623110

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2002635900 Active DE60235900D1 (en) 2001-09-27 2002-09-25 osuppressivum

Country Status (7)

Country Link
US (1) US6963012B2 (en)
EP (1) EP1431275B1 (en)
JP (1) JP4152884B2 (en)
AT (1) AT463478T (en)
CA (1) CA2460640C (en)
DE (1) DE60235900D1 (en)
WO (1) WO2003029184A1 (en)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1431284B1 (en) * 2001-09-27 2007-11-21 Kyorin Pharmaceutical Co., Ltd. Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
CA2473461C (en) 2002-01-11 2011-11-01 Sankyo Company, Limited Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
EP1505959B1 (en) 2002-05-16 2008-10-29 Novartis AG Use of edg receptor binding agents in cancer
CA2498944C (en) * 2002-09-19 2011-05-17 Yasushi Kohno Amino alcohol derivatives, salts thereof and immunosuppressive agents
EP2251007A3 (en) 2002-09-24 2011-03-23 Novartis AG Sphingosine-1-phosphate (S1P) receptor agonists for use in the treatment of demyelinating diseases
GR1005052B (en) 2003-04-08 2005-11-30 Novartis Ag Compositions comprising s1p respector agonist
ES2383298T3 (en) * 2003-04-30 2012-06-20 Novartis Ag Amino-propanol derivatives as sphingosine-1-phosphate receptor modulators
GB0320638D0 (en) 2003-09-03 2003-10-01 Novartis Ag Organic compounds
GB0324210D0 (en) 2003-10-15 2003-11-19 Novartis Ag Organic compounds
GB0329498D0 (en) 2003-12-19 2004-01-28 Novartis Ag Organic compounds
TW200526548A (en) * 2003-12-25 2005-08-16 Sankyo Co Ether derivatives
BRPI0507944A (en) * 2004-02-24 2007-07-24 Sankyo Co Pharmaceutical composition
EP2363149A1 (en) 2004-05-03 2011-09-07 Novartis AG Combinations comprising a S1P receptor agonist and a JAK3 kinase inhibitor
KR101178318B1 (en) * 2004-07-16 2012-08-29 교린 세이야꾸 가부시키 가이샤 Method of effectively using medicine and method concerning prevention of side effect
TW200611687A (en) * 2004-07-29 2006-04-16 Sankyo Co Pharmaceutical compositions used for immunosuppressant
PT1773307E (en) 2004-07-30 2015-01-14 Novartis Ag Compound formulations of 2-amino-1,3-propanediol compounds
EP2511262B1 (en) 2004-10-12 2017-02-01 Kyorin Pharmaceutical Co., Ltd. Process for producing 2-amino-2-[2-[4-(3-benzyloxy-phenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride
KR20140095109A (en) 2004-11-29 2014-07-31 노파르티스 아게 Dosage regimen of an s1p receptor agonist
GB0500020D0 (en) 2005-01-04 2005-02-09 Novartis Ag Organic compounds
GB0504544D0 (en) 2005-03-04 2005-04-13 Novartis Ag Organic compounds
TWI418350B (en) 2005-06-24 2013-12-11 Sankyo Co Use of pharmaceutical compositions comprising ppar modulator
AR057455A1 (en) * 2005-07-22 2007-12-05 Merck & Co Inc Inhibitors and HIV reverse transcriptase pharmaceutical composition
EP2295049B1 (en) * 2005-09-09 2014-11-26 Novartis AG Treatment of autoimmune diseases
BRPI0617077A2 (en) 2005-10-07 2015-01-06 Kyorin Seiyaku Kk Therapeutic agent for treatment of liver diseases containing 2-amine-1, 3-propanediol derivative as active ingredient, and method for treatment of liver diseases
TWI389683B (en) * 2006-02-06 2013-03-21 Kyorin Seiyaku Kk A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
CN101466727B (en) 2006-04-11 2012-10-17 诺瓦提斯公司 Hcv/hiv inhibitor and their uses
US8114902B2 (en) 2006-04-28 2012-02-14 Mitsubishi Tanabe Pharma Corporation 2-aminobutanol compound and use thereof for medical purposes
TW200815600A (en) 2006-08-04 2008-04-01 Daiichi Sankyo Co Ltd An enzyme for phosphorizing a medicine
MY146775A (en) * 2006-08-08 2012-09-28 Kyorin Seiyaku Kk Amino alcohol derivative and immunosuppressive agent having same as an active ingredient
ES2438265T3 (en) 2006-08-08 2014-01-16 Kyorin Pharmaceutical Co., Ltd. Aminophosphoric acid ester derivative and S1P receptor modulator containing it as active ingredient
RU2453532C2 (en) * 2007-06-14 2012-06-20 Мицубиси Танабе Фарма Корпорейшн Amine compound and pharmaceutical use thereof
AR068986A1 (en) 2007-10-12 2009-12-23 Novartis Ag Compositions comprising modulators of receptor sphingosine-1 phosphate (S1P)
US7816435B2 (en) * 2007-10-31 2010-10-19 Momentive Performance Materials Inc. Halo-functional silane, process for its preparation, rubber composition containing same and articles manufactured therefrom
US8476305B2 (en) 2008-02-07 2013-07-02 Kyorin Pharmaceutical Co., Ltd. Therapeutic agent or prophylactic agent for inflammatory bowel disease comprising amino alcohol derivative as active ingredient
ES2617628T3 (en) 2008-03-17 2017-06-19 Actelion Pharmaceuticals Ltd. Dosing regimen for a selective S1P1 receptor agonist
CN103396346A (en) * 2008-05-19 2013-11-20 杏林制药株式会社 Method for producing optically active aminoalcohol derivative
MX2010012676A (en) * 2008-05-20 2011-05-10 Kyorin Seiyaku Kk Agent for induction/maintenance of remission.
GB0901835D0 (en) 2009-02-04 2009-03-11 Syngenta Ltd Novel herbicides
GB0901834D0 (en) 2009-02-04 2009-03-11 Syngenta Ltd Novel herbicides
US8512690B2 (en) 2009-04-10 2013-08-20 Novartis Ag Derivatised proline containing peptide compounds as protease inhibitors
US20110182850A1 (en) 2009-04-10 2011-07-28 Trixi Brandl Organic compounds and their uses
WO2011004604A1 (en) 2009-07-09 2011-01-13 杏林製薬株式会社 Diphenyl sulfide derivatives and medicines containing same as active ingredient
KR101148098B1 (en) 2010-04-30 2012-05-22 원광대학교산학협력단 Composition comprising 1-[4-4-nitro-penoxy-phenyl]-propane-1-one for preventing and treating the disease caused by Toxoplasmosis and Coccidium
TW201201814A (en) * 2010-05-06 2012-01-16 Novartis Ag Treatment of autoimmune diseases
BR112012028248A2 (en) 2010-05-06 2016-08-02 Novartis Ag diaryl sulfide derivatives, their use, and kit
US9011833B2 (en) 2010-10-08 2015-04-21 Novartis Ag Vitamin E formulations of sulfamide NS3 inhibitors
TWI519539B (en) 2010-12-21 2016-02-01 Kyorin Seiyaku Kk Diphenyl sulfide derivatives and pharmaceuticals as an active ingredient
CN102863345A (en) * 2011-07-06 2013-01-09 中国医学科学院药物研究所 Amino propylene glycol derivative, preparation method of amino propylene glycol derivative, medicine composition of amino propylene glycol derivative and application of amino propylene glycol derivative
DK2731935T3 (en) * 2011-07-13 2016-06-06 Basf Agro Bv Fungicide substituted 2- [2-halogenalkyl-4- (phenoxy) -phenyl] -1- [1,2,4] triazol-1-ylethanol compounds
MX2014000039A (en) 2011-07-15 2014-02-17 Basf Se Fungicidal alkyl-substituted 2-[2-chloro-4-(4-chloro-phenoxy)-phe nyl]-1-[1,2,4]triazol-1-yl-ethanol compounds.
BR112014000538A2 (en) 2011-07-15 2016-08-23 Basf Se compounds, process for preparing the compounds, agrochemical compositions, use of the compounds and seed coated
MX2014000824A (en) 2011-08-15 2014-02-27 Basf Se Fungicidal substituted 1-{2-[2-halo-4-(4-halogen-phenoxy)-phenyl] -2-alkoxy-3-methyl-butyl}-1h-[1,2,4]triazole compounds.
WO2013024082A1 (en) 2011-08-15 2013-02-21 Basf Se Fungicidal substituted 1-{2-cyclyloxy-2-[2-halo-4-(4-halogen-phenoxy)-phenyl]-ethyl}-1h-[1,2,4]triazole compounds
BR112014003216A2 (en) 2011-08-15 2017-04-25 Basf Se compounds, processes for preparing compounds of formula i, agrochemical compositions, use of compounds of formula i or viii and use of at least one compound of formula i or viii
ES2665336T3 (en) 2012-04-23 2018-04-25 Mitsubishi Tanabe Pharma Corporation Amine compound and its use for medical purposes
CN104844486B (en) * 2014-02-17 2018-10-30 中国医学科学院药物研究所 Amido propylene glycol derivative, preparation method and its pharmaceutical composition and purposes
EA032078B1 (en) 2014-06-25 2019-04-30 Басф Агро Б.В. Pesticidal compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69321823D1 (en) * 1992-10-21 1998-12-03 Yoshitomi Pharmaceutical 2-amino-1, 3- propanediol compound and immunosuppressium
KR100358922B1 (en) * 1994-08-22 2003-01-24 미쯔비시 웰 파마 가부시키가이샤 Benzene compound and medicinal use thereof
SI1002792T1 (en) 1997-04-04 2004-12-31 Mitsubishi Pharma Corporation 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same

Also Published As

Publication number Publication date
EP1431275A1 (en) 2004-06-23
JPWO2003029184A1 (en) 2005-01-13
US20040242654A1 (en) 2004-12-02
JP4152884B2 (en) 2008-09-17
AT463478T (en) 2010-04-15
CA2460640C (en) 2011-03-29
EP1431275B1 (en) 2010-04-07
US6963012B2 (en) 2005-11-08
EP1431275A4 (en) 2006-05-31
CA2460640A1 (en) 2003-04-10
WO2003029184A1 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
DK1427285T3 (en) Anthranilamidarthropodicidbehandling
DE60227511D1 (en) umzeitkodierung
DE60230050D1 (en) Soft-polyvinylchloride
DE60234019D1 (en) Erststufenkupplung
DE60236021D1 (en) Kryotemperaturüberwachung
DK1381412T3 (en) Ernæringssætadapter
DE60220795D1 (en) Verschleissanordnung
DE60221810D1 (en) Ballonfalttechnologie
DK1470358T3 (en) Modhageklemme
DE60238211D1 (en) nkopf
DE60226209D1 (en) Wendefrässchneidplatte
DK1351734T3 (en) Törpulverinhalator
DE60213260D1 (en) Intraokularlinsenbestimmungssystem
DE60229151D1 (en) Vanadium - / - polyhalid-redoxflussbatterie
DE60235900D1 (en) osuppressivum
DE60225669D1 (en) erlumina
DE60206512D1 (en) RAPANYCIN29-enols
DE60224470D1 (en) Hüftimplantataufbau
DE60227840D1 (en) nanokristlallstrukturen
DE60232261D1 (en) En
DE60237988D1 (en) enstands
DE60230521D1 (en) Fluiddruckreduzierventil
DE60239731D1 (en) ussleistung
DE60226770D1 (en) Verkokungskammerentleerungssystem
DE60227316D1 (en) En

Legal Events

Date Code Title Description
8364 No opposition during term of opposition